» Articles » PMID: 20079598

Telephone Nurse Counseling for Medication Adherence in Ulcerative Colitis: a Preliminary Study

Overview
Publisher Elsevier
Specialties Health Services
Nursing
Date 2010 Jan 19
PMID 20079598
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Adherence is challenging in episodic chronic conditions that require medication during both symptomatic and quiescent periods, such as ulcerative colitis (UC). Adherence for these conditions is under-studied. This study was a preliminary test of telephone nurse counseling to address cognitive and emotional barriers to adherence in UC.

Methods: 524 people taking mesalamine for UC were referred by their health care providers, and 278 (53%) enrolled. There were no demographic differences between program participants and nonparticipants. Participants reported multiple comorbidities and concomitant medications. All participants received telephone follow-up (M = 2.1 calls) from a registered nurse who used cognitive-behavioral and motivational interviewing counseling techniques. Adherence measured by structured interview was compared to a population baseline using a binomial test.

Results: Attrition was 51% over 6 months but was unrelated to adherence. Participants had better adherence than the expected population rate, with a significant dose-response effect. Reasons for nonadherence were primarily psychological or efficacy-related.

Conclusion: Adherence following intervention was better than typical mesalamine adherence. Self-efficacy predicted adherence, but demographic and clinical variables did not. Adherent participants reported more adverse events.

Practice Implications: Attention to patients' cognitive and emotional reactions may help to improve adherence in episodic chronic diseases such as UC.

Citing Articles

Comparing the effectiveness of online individualized transdiagnostic treatment with acceptance and commitment therapy on medication adherence, gastrointestinal symptoms and perceived stress of patients with irritable bowel syndrome.

Shahkaram H, Sadeghi A, Masjedi Arani A, Bakhtiari M, Kianimoghadam A Gastroenterol Hepatol Bed Bench. 2024; 17(3):288-296.

PMID: 39308538 PMC: 11413384. DOI: 10.22037/ghfbb.v17i3.2920.


Evaluation of Telemedicine Consultations Using Health Outcomes and User Attitudes and Experiences: Scoping Review.

Dhunnoo P, Kemp B, McGuigan K, Mesko B, ORourke V, McCann M J Med Internet Res. 2024; 26:e53266.

PMID: 38980704 PMC: 11267102. DOI: 10.2196/53266.


Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions.

Mercuri C, Catone M, Bosco V, Guillari A, Rea T, Doldo P Healthcare (Basel). 2024; 12(12).

PMID: 38921325 PMC: 11204356. DOI: 10.3390/healthcare12121210.


Summary of the best evidence on self-management support schemes for patients with inflammatory bowel disease based on mobile health systems.

Ren C, Zhou Y, Cai Q, Zhou M Digit Health. 2024; 10:20552076241261906.

PMID: 38868366 PMC: 11168054. DOI: 10.1177/20552076241261906.


Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?.

Gravina A, Pellegrino R, Durante T, Palladino G, DOnofrio R, Mammone S World J Methodol. 2023; 13(4):194-209.

PMID: 37771865 PMC: 10523254. DOI: 10.5662/wjm.v13.i4.194.